The Westminster lensArchive · §02 Speeches · 2,063 contributions

Speeches by Bryant.

Every Hansard contribution by Chris Bryant this parliament, most recent first. Back to the MP page for the headline figures and analysed positions.

Showing 1,6611,680 of 2,063 contributions · most-recent first

← PreviousPage 84 of 104Next →
DateDebate & contributionWords
12 Feb 2025Data (Use and Access) Bill [Lords]

rose—

technologyeconomy-jobs
1
12 Feb 2025Animal Testing

I cannot provide the hon. Gentleman with that timeline now. We are working at pace trying to put together a practicable policy and a strategy which, as I said, we will publish by the end of the year. He makes a perfectly good point about the complexities. It will not be easy for the MHRA to meet its international commi

healthtechnology
95
12 Feb 2025Animal Testing

I did not know that my hon. Friend had taken over the APPG; it is a good thing that it exists. We will work very closely with the APPG. Whether I am the right Minister or whether there is a more intelligent Minister—or a more charming one, perhaps—who might be of more assistance to her, I will make sure that she gets a

healthtechnology
68
12 Feb 2025Animal Testing

Our aim is to phase out animal testing as soon as is practicable. We have been working closely, and it was a manifesto commitment of ours. We have been meeting scientists and other Departments, because this area is not the sole responsibility of the Department for Science, Innovation and Technology. We intend to publis

healthtechnology
69
12 Feb 2025Innovation: Livingston

Livingston is a remarkable example of where investment can make a significant difference. I am really pleased that the chief executive of SilviBio recently received a women in innovation award for innovation in science. My hon. Friend is absolutely right that innovation accelerator projects in Glasgow and across the wh

technologyeconomy-jobslocal-government
101
12 Feb 2025Innovation: Livingston

We have already spent £4 million on projects in my hon. Friend’s constituency, including £88,000 on SilviBio Ltd. I am very proud of the fact that we have been able to commit, in 2025-26, to a record amount of money—£20.4 billion—for research and development.

technologyeconomy-jobslocal-government
44
12 Feb 2025Data (Use and Access) Bill [Lords]

Oh dear, she is. I am not sure about having world-class rugby players on the Committee, but it is one of the issues I am very happy to debate with my hon. Friend. We want to make sure we have got it right and that we manage to embrace everybody as much as we can.

technologyeconomy-jobs
55
12 Feb 2025Data (Use and Access) Bill [Lords]

I think it might be easier if I respond to that now. Yes, I completely and utterly agree with the right hon. Gentleman. That is our settled view. We want to get to a process where there is more licensing of content, and we have said that repeatedly. It is one of the aims of our consultation. He says that copyright does

technologyeconomy-jobs
94
12 Feb 2025Data (Use and Access) Bill [Lords]

No, it is not. What is true is that, as I said, we want to get to a concrete idea of what transparency might look like. Not enough work has been done in the EU or in different territories—in the United States of America, for instance, where different states have different arrangements—and we need to do more about what

technologyeconomy-jobs
173
12 Feb 2025Data (Use and Access) Bill [Lords]

I will in a moment. That is why I am keen on not selling the pass on that possibility by having undermined it before we get there.

technologyeconomy-jobs
27
3 Feb 2025AstraZeneca

I could read out the long list of investments made in the last few months, except I do not think that Mr Speaker would let me. I do not think we have time, and you would get bored with me, Mr Speaker. The hon. Member makes an important point. At the moment, I am engaged in negotiations on a significant possible investm

economy-jobstechnology
239
3 Feb 2025AstraZeneca

First, let me clear up a point about national insurance contributions. I know that the Conservative party likes to bang on about them, but many people do not know that 50% of businesses and organisations in the UK will pay either exactly the same amount of national insurance or less. That fact is not often, if ever, re

economy-jobstechnology
102
3 Feb 2025AstraZeneca

It is almost sad, sometimes. I just wish the hon. Member had been here for the last 14 years. I wish he had been here when we had endless strikes in every single part of every Department and we could not get the NHS waiting lists dealt with because we were not paying our nurses and our doctors properly. The first thing

economy-jobstechnology
120
3 Feb 2025AstraZeneca

I think the hon. Gentleman needs to speak to the hon. Member who spoke earlier—oh, he’s left. I actually believe that the vaccines saved lives; I do not believe that they lost people their lives. I am afraid that the hon. Gentleman and I will never be united on that front.

economy-jobstechnology
51
3 Feb 2025AstraZeneca

Some of what I have already pointed out is really important. We have already said that we will have the lowest corporation tax rate in the G7, at 25%, and we are sticking with that. We have made sure that we are investing in our public services so that people can have a guarantee of proper public services in this count

economy-jobstechnology
141
3 Feb 2025AstraZeneca

It does not send any kind of message like that. The point is that in the UK we have secured dramatic amounts of additional investment since the general election. What is interesting is that all the Conservative Members are praising something that was never delivered by the previous Government; it was only announced. It

economy-jobstechnology
122
3 Feb 2025AstraZeneca

If I might just refer to the first comment first, I am the Member for Rhondda and Ogmore, so I fully understand that investment in one part of the country is obviously great for that part of the country, but it does not necessarily mean that every part of the country is rising with everybody else. Trying to make sure t

economy-jobstechnology
162
3 Feb 2025AstraZeneca

The hon. Lady’s first point was on the voluntary scheme for branded medicines pricing and access, which is reduced to an acronym that is not really an acronym: VPAG. This is, as it says on the tin, a voluntary agreement between Government, the pharmaceutical industry and the NHS, which is designed specifically to ensur

economy-jobstechnology
184
3 Feb 2025AstraZeneca

I would be delighted to meet my hon. Friend knows, as she knows, although I think it would probably be more useful for her if she were to meet Lord Vallance, who is the Minister for life sciences. My hon. Friend is absolutely right; we would of course much prefer this investment to go ahead and to have been able to get

economy-jobstechnology
113
3 Feb 2025AstraZeneca

Not necessarily for this specific deal, but certainly for a deal with AstraZeneca, yes.

economy-jobstechnology
14
← PreviousPage 84 of 104 · click a debate to open the transcript with this MP’s speeches highlightedNext →
Sources
SourceHansard · official report
MethodEach row is one contribution (intervention or speech). Word count from the official text.